Reviva Pharmaceuticals RVPH Stock
Reviva Pharmaceuticals Price Chart
Reviva Pharmaceuticals RVPH Financial and Trading Overview
| Reviva Pharmaceuticals stock price | 0.7 USD |
| Previous Close | 0.61 USD |
| Open | 0.62 USD |
| Bid | 0.66 USD x 2589100 |
| Ask | 0.7 USD x 204700 |
| Day's Range | 0.62 - 0.7 USD |
| 52 Week Range | 0.26 - 17.2 USD |
| Volume | 17.81K USD |
| Avg. Volume | 581.82K USD |
| Market Cap | 9.15M USD |
| Beta (5Y Monthly) | 0.564 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25 USD |
RVPH Valuation Measures
| Enterprise Value | -12807914 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.36736843 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.5128582 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Reviva Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.564 |
| 52-Week Change | -95.66% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 17.2 USD |
| 52 Week Low | 0.26 USD |
| 50-Day Moving Average | 0.68 USD |
| 200-Day Moving Average | 5.68 USD |
RVPH Share Statistics
| Avg. Volume (3 month) | 581.82K USD |
| Avg. Daily Volume (10-Days) | 66.85K USD |
| Shares Outstanding | 13.11M |
| Float | 11.38M |
| Short Ratio | 3.35 |
| % Held by Insiders | 7.72% |
| % Held by Institutions | 22.62% |
| Shares Short | 1.87M |
| Short % of Float | 14.94% |
| Short % of Shares Outstanding | 14.57% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.091% |
| Return on Equity (ttm) | -256.20% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -16628049 USD |
| Diluted EPS (ttm) | -3.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 22.19M USD |
| Total Cash Per Share (mrq) | 1.69 USD |
| Total Debt (mrq) | 231.27K USD |
| Total Debt/Equity (mrq) | 1.33 USD |
| Current Ratio (mrq) | 3.85 |
| Book Value Per Share (mrq) | 1.361 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20201740 USD |
| Levered Free Cash Flow (ttm) | -14494285 USD |
Profile of Reviva Pharmaceuticals
| Country | United States |
| State | CA |
| City | Cupertino |
| Address | 10080 N. Wolfe Road |
| ZIP | 95014 |
| Phone | 408 501 8881 |
| Website | https://www.revivapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Q&A For Reviva Pharmaceuticals Stock
What is a current RVPH stock price?
Reviva Pharmaceuticals RVPH stock price today per share is 0.7 USD.
How to purchase Reviva Pharmaceuticals stock?
You can buy RVPH shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Reviva Pharmaceuticals?
The stock symbol or ticker of Reviva Pharmaceuticals is RVPH.
Which industry does the Reviva Pharmaceuticals company belong to?
The Reviva Pharmaceuticals industry is Biotechnology.
How many shares does Reviva Pharmaceuticals have in circulation?
The max supply of Reviva Pharmaceuticals shares is 13.11M.
What is Reviva Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Reviva Pharmaceuticals PE Ratio is now.
What was Reviva Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Reviva Pharmaceuticals EPS is -3.33 USD over the trailing 12 months.
Which sector does the Reviva Pharmaceuticals company belong to?
The Reviva Pharmaceuticals sector is Healthcare.
Reviva Pharmaceuticals RVPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}